quinoxalines has been researched along with Amyloid Deposits in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, M; Kimura, H; Liu, B; Ono, M; Saji, H | 1 |
| Cui, M; Jia, H; Jia, J; Li, Z; Liu, B; Ono, M; Saji, H; Wang, X; Yang, Y; Yu, P; Zhang, J; Zhang, X | 1 |
2 other study(ies) available for quinoxalines and Amyloid Deposits
| Article | Year |
|---|---|
Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Autoradiography; Brain; Disease Models, Animal; Humans; Iodine Radioisotopes; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Protein Binding; Quinoxalines; Radiography; Radiopharmaceuticals; Tissue Distribution | 2011 |
¹⁸F-labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.
Topics: Amyloid beta-Peptides; Animals; Autoradiography; Brain; Chromatography, High Pressure Liquid; Contrast Media; Fluorine Radioisotopes; Humans; Male; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Positron-Emission Tomography; Quinoxalines; Radiography; Staining and Labeling; Tissue Distribution | 2012 |